Artemin Stimulates Oncogenicity and Invasiveness of Human Endometrial Carcinoma Cells

Author:

Pandey Vijay1,Qian Peng-Xu2,Kang Jian1,Perry Jo K.1,Mitchell Murray D.1,Yin Zhinan3,Wu Zheng-Sheng4,Liu Dong-Xu1,Zhu Tao2,Lobie Peter E.5

Affiliation:

1. The Liggins Institute (V.P., J.K., J.K.P., M.D.M., D.-X.L., P.E.L.) University of Auckland, Private Bag 92019, Auckland, New Zealand

2. Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences (P.-X.Q., T.Z.), University of Science and Technology of China, Hefei, Anhui 230027, People’s Republic of China

3. School of Life Science (Z.Y.), Nankai University, Tianjin 300071, People’s Republic of China

4. Department of Pathology (Z.-S.W.), Anhui Medical University, Hefei, Anhui 230027, People’s Republic of China

5. Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences (P.E.L.), University of Auckland, Private Bag 92019, Auckland, New Zealand

Abstract

Here, we provide evidence for a functional role of artemin (ARTN) in progression of endometrial carcinoma (EC). Increased ARTN protein expression was observed in EC compared with normal endometrial tissue, and ARTN protein expression in EC was significantly associated with higher tumor grade and invasiveness. Forced expression of ARTN in EC cells significantly increased total cell number as a result of enhanced cell cycle progression and cell survival. In addition, forced expression of ARTN significantly enhanced anchorage-independent growth and invasiveness of EC cells. Moreover, forced expression of ARTN increased tumor size in xenograft models and produced highly proliferative, poorly differentiated, and invasive tumors. The ARTN-stimulated increases in oncogenicity and invasion were mediated by increased expression and activity of AKT1. Small interfering RNA-mediated depletion or antibody inhibition of ARTN significantly reduced oncogenicity and invasion of EC cells. Thus, inhibition of ARTN may be considered as a potential therapeutic strategy to retard progression of EC.

Publisher

The Endocrine Society

Subject

Endocrinology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3